Shandong Anshun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TAZOBACTAM (NON-STERILE API), with a corresponding US DMF Number 33978.
Remarkably, this DMF maintains an Active status since its submission on July 30, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2019, and payment made on July 31, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II